Mario Fernández-Ruiz , Juan José Castón , José Luis del Pozo , Jordi Carratalà , Jesús Fortún , Miguel Salavert , Julián Torre-Cisneros , José María Aguado , on behalf of the members of the OPENIN (Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones) Group , Ana Fernández Cruz , Ana Ventura , Belén Loeches , Carlos Dueñas , Cristina Tomás , David Navarro , Rosa Oltra , Elena Resino-Foz , Elisa García Vázquez , Enrique Míguez , Esperanza Merino , Vicente Abril
{"title":"如何优化肺炎的诊断和治疗方法?专家建议。","authors":"Mario Fernández-Ruiz , Juan José Castón , José Luis del Pozo , Jordi Carratalà , Jesús Fortún , Miguel Salavert , Julián Torre-Cisneros , José María Aguado , on behalf of the members of the OPENIN (Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones) Group , Ana Fernández Cruz , Ana Ventura , Belén Loeches , Carlos Dueñas , Cristina Tomás , David Navarro , Rosa Oltra , Elena Resino-Foz , Elisa García Vázquez , Enrique Míguez , Esperanza Merino , Vicente Abril","doi":"10.1016/j.eimce.2024.07.001","DOIUrl":null,"url":null,"abstract":"<div><div>Pneumonia continues to be one of the most frequent infectious syndromes and a relevant cause of death and health resources utilization. The OPENIN (“Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones”) Group is composed of Infectious Diseases specialists and Microbiologists and aims at generating recommendations that can contribute to improve the approach to processes with high impact on the health system. Such task relies on a critical review of the available scientific evidence. The first Group meeting (held in October 2023) aimed at answering the following questions: Can we optimize the syndromic and microbiological diagnosis of pneumonia? Is it feasible to safely shorten the length of antibiotic therapy? And, is there any role for the immunomodulatory strategies based on the adjuvant use of steroids, macrolides or immunoglobulins? The present review summarizes the literature reviewed for that meeting and offers a series of expert recommendations.</div></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"42 8","pages":"Pages 442-452"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations\",\"authors\":\"Mario Fernández-Ruiz , Juan José Castón , José Luis del Pozo , Jordi Carratalà , Jesús Fortún , Miguel Salavert , Julián Torre-Cisneros , José María Aguado , on behalf of the members of the OPENIN (Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones) Group , Ana Fernández Cruz , Ana Ventura , Belén Loeches , Carlos Dueñas , Cristina Tomás , David Navarro , Rosa Oltra , Elena Resino-Foz , Elisa García Vázquez , Enrique Míguez , Esperanza Merino , Vicente Abril\",\"doi\":\"10.1016/j.eimce.2024.07.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pneumonia continues to be one of the most frequent infectious syndromes and a relevant cause of death and health resources utilization. The OPENIN (“Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones”) Group is composed of Infectious Diseases specialists and Microbiologists and aims at generating recommendations that can contribute to improve the approach to processes with high impact on the health system. Such task relies on a critical review of the available scientific evidence. The first Group meeting (held in October 2023) aimed at answering the following questions: Can we optimize the syndromic and microbiological diagnosis of pneumonia? Is it feasible to safely shorten the length of antibiotic therapy? And, is there any role for the immunomodulatory strategies based on the adjuvant use of steroids, macrolides or immunoglobulins? The present review summarizes the literature reviewed for that meeting and offers a series of expert recommendations.</div></div>\",\"PeriodicalId\":72916,\"journal\":{\"name\":\"Enfermedades infecciosas y microbiologia clinica (English ed.)\",\"volume\":\"42 8\",\"pages\":\"Pages 442-452\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Enfermedades infecciosas y microbiologia clinica (English ed.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2529993X24001771\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2529993X24001771","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
肺炎仍然是最常见的感染综合征之一,也是导致死亡和医疗资源使用的一个重要原因。OPENIN ("Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones")小组由传染病专家和微生物学家组成,旨在提出有助于改善对医疗系统有重大影响的流程的建议。这项任务依赖于对现有科学证据的严格审查。小组第一次会议(2023 年 10 月举行)旨在回答以下问题:我们能否优化肺炎的综合征和微生物诊断?安全缩短抗生素治疗时间是否可行?基于类固醇、大环内酯类药物或免疫球蛋白辅助使用的免疫调节策略是否有任何作用?本综述总结了此次会议的文献综述,并提出了一系列专家建议。
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations
Pneumonia continues to be one of the most frequent infectious syndromes and a relevant cause of death and health resources utilization. The OPENIN (“Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones”) Group is composed of Infectious Diseases specialists and Microbiologists and aims at generating recommendations that can contribute to improve the approach to processes with high impact on the health system. Such task relies on a critical review of the available scientific evidence. The first Group meeting (held in October 2023) aimed at answering the following questions: Can we optimize the syndromic and microbiological diagnosis of pneumonia? Is it feasible to safely shorten the length of antibiotic therapy? And, is there any role for the immunomodulatory strategies based on the adjuvant use of steroids, macrolides or immunoglobulins? The present review summarizes the literature reviewed for that meeting and offers a series of expert recommendations.